Cardlytics Inc. (NASDAQ:CDLX) saw an upside of 4.51% to close Friday at $12.75 after adding $0.55 on the day. The 5-day average trading volume is 566,700 shares of the company’s common stock. It has gained $13.71 in the past week and touched a new high 1 time within the past 5 days. An average of 816,420 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 761,608.
CDLX’s 1-month performance is 43.58% or $2.84 on its low of $8.44 reached on 07/24/23. The company’s shares have touched a 52-week low of $2.57 and high of $16.87, with the stock’s rally to the 52-week high happening on 08/02/23. YTD, CDLX has achieved 120.59% or $6.97 and has reached a new high 11 times. However, the current price is down -24.42% from the 52-week high price.
Insider Transactions
CDLX stock investors last saw insider trading activity on Aug 09.Lynton Nicholas Hollmeyer (Chief Legal & Privacy Officer) most recently sold 7,500 shares at $13.67 per share on Aug 09. This transaction cost the insider $102,525. Chief Legal & Privacy Officer, Lynton Nicholas Hollmeyer, sold 5,122 shares at a price of $13.50 on Aug 07. Then, on Jul 19, Chief Financial Officer Christiansen Andrew sold 13,404 shares at a price of $10.20 per share. This transaction amounted to $136,721.
Valuation Metrics
CDLX stock has a beta of 1.86. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 1.55 while the price-to-book (PB) in the most recent quarter is 1.88.
Cardlytics Inc.’s quick ratio for the period ended June 29 was 1.20, with the current ratio over the same period at 1.20. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.96, while the total debt to equity was 1.09. In terms of profitability, the gross margin trailing 12 months is 49.80%. The trailing 12-month EBITDA margin is -30.75%. The firm’s gross profit as reported stood at $112.63 million against revenue of $298.54 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income shrunk -437.18% to -$23.51 million, while revenue of $13.61 million was 157.89% off the previous quarter. Analysts expected CDLX to announce -$0.35 per share in earnings in its latest quarter, but it posted -$0.24, representing a 31.40% surprise. EBITDA for the quarter stood at more than -$15.74 million. CDLX stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 397.21 million, with total debt at $262.24 million. Shareholders hold equity totaling $37.72 million.
Let’s look briefly at Cardlytics Inc. (CDLX) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 18 August was 54.29% to suggest the stock is trending Neutral, with historical volatility in this time period at 80.38%.
The stock’s 5-day moving average is $12.99, reflecting a +2.66% or $0.33 change from its current price. CDLX is currently trading +45.71% above its 20-day SMA, +382.95% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by +141.02% and SMA200 by+35.21%.
Stochastic %K and %D was 42.93% and 54.48% and the average true range (ATR) pointed at 1.14. The RSI (14) points at 58.22%, while the 14-day stochastic is at 43.02% with the period’s ATR at 1.09. The stock’s 9-day MACD Oscillator is pointing at -0.48 and -0.63 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Cardlytics Inc. (NASDAQ: CDLX), Wells Fargo downgraded it to an Underweight rating. They previously had an Equal weight rating on the stock.
What is CDLX’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $15.00 and a high of $19.00, with their median price target at $17.00. Looking at these predictions, the average price target given by analysts is for Cardlytics Inc. (CDLX) stock is $17.00.
